Bond market is experiencing one of the greatest bear cycles in the last 240 years. Read why I think investors should make ...

During Q4 2024, the Miller Deep Value Select strategy generated net returns of +3.59% ahead of both the S&P 1500 Value Index ...

Dividend investing has a lot going for it. However, most dividend ETFs and dividend portfolios are missing an important ...

Medical Properties Trust investors took a hit from Prospect Medical's bankruptcy filings, but stock has largely consolidated.

The John Hancock Financial Opportunities Fund is a compelling long-term investment in financials, despite its premium. Click ...

Most publicly traded US health insurers are forecast to report sequential revenue and earnings declines for the fourth ...

EQT is an S&P 500 component, but somewhat under the radar. My assessment is driven by technical and quant analysis, as ...

The banking industry is just about to go into a major change, and investors need to be aware of what is going on. Explore ...

Dell's stock is a strong buy with a $180 price target, driven by its cheap valuation and AI potential, despite risks like ...

Mercury Systems struggles with inefficiencies but has a strong backlog. See why MRCY stock offers potential as it focuses on ...

Johnson & Johnson has underperformed its lerge-cap healthcare peers and the S&P 500, with an -8% decline over the past year.

Devastating wildfires continue to rage in the Los Angeles area, and our hearts go out to the families and communities that ...